TREATMENT OF PIGS WITH PCV2 ANTIGEN

The present invention relates to a method for the treatment or prophylaxis of a PCV2 infection or for reduction of clinical symptoms caused by or associated with a PCV2 infection in animals a) having anli-PCV2 antibodies and/or b) being young piglets of 1 to 22 days of age, comprising the step of ad...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	KIXMOELLER, MARION, ORVEILLON, FRANCOIS-XAVIER, FACHINGER, VICKY, PIONTKOWSKI, MICHAEL, LISCHEWSKI, AXEL, ELBERS, KNUT, FREIIN VON RICHTHOFEN, ISABELLE
Format:	Patent
Sprache:	eng ; fre
Schlagworte:	CHEMISTRY HUMAN NECESSITIES HYGIENE INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES MEASURING MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PHYSICS PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS TESTING
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The present invention relates to a method for the treatment or prophylaxis of a PCV2 infection or for reduction of clinical symptoms caused by or associated with a PCV2 infection in animals a) having anli-PCV2 antibodies and/or b) being young piglets of 1 to 22 days of age, comprising the step of administering an effective amount of a PCV2 antigen to that animal in need of such treatment. Preferably, those animals are pigs or young piglets. L'invention concerne un procédé de traitement ou de prophylaxie d'une infection par le PCV2 ou de réduction de symptômes cliniques causés par, ou associés à, une infection par le PCV2 chez des animaux a) ayant des anticorps anti-PCV2 et/ou b) étant de jeunes porcelets âgés de 1 à 22 jours, comprenant l'étape d'administration d'une quantité efficace d'un antigène de PCV2 à cet animal ayant besoin d'un tel traitement. De préférence, ces animaux sont des porcs ou de jeunes porcelets.